Disclaimer

By using Prism MarketView and any subdomain or premium service offered by Prism MarketView, hereafter referred to as “Services”, you acknowledge that (i) any and all Services provided are for informational purposes only and do not constitute a recommendation for any particular stock, company, investment, commodity, security, transaction, or any other method of trading featured in any place on Prism MarketView(ii) Prism MarketView does not guarantee the accuracy, completeness, or timeliness of the Services provided (iii) views offered by any Services, outside contributors, columnists, partners and employees are not specifically endorsed by Prism MarketView nor does Prism MarketView hold any responsibility or liability for any actions, negative or otherwise, taken by you either directly or indirectly as a result of participating in any Services offered.

Prism MarketView, its employees, partners, and any other representatives will not, either directly or indirectly, be held liable, accountable, or responsible, in any capacity, to you or to any other person for any (i) errors, inaccuracies, or omissions from the Services including, but not limited to, quotes, rumors, chatter, financial data, and reports; (ii) interruptions, delays, or errors in delivery or transmission of the Services, (iii) damages or losses arising there from or occasioned because of, or by any reason of nonperformance.

Some of Prism MarketView’s content may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed information may be correlated with increased volatility in securities, price movements based on unofficial information may change quickly based on increased speculation, clarification, or release of official news.

PCG Advisory, Inc., (PCG) is an affiliate of this website. PCG provides strategic advisory, investor relations and/or public relations services to emerging-growth companies.

More detailed disclosure regarding fees paid is available at www.pcgadvisory.com and upon request. PCG is not a broker/dealer or registered investment advisor. Information contained throughout this site is not an offer to buy or sell securities. Information presented on this site is solely for informative purposes, and is not intended, nor should they be construed, as investment advice.

The information provided including news, blogs, corporate profiles, and other material is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. The companies featured on this site are typically development-stage and investment in such securities is considered highly speculative and carries a high degree of risk. Complete loss of capital is a distinct possibility. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at www.sec.gov and the Financial Industry Regulatory Authority (FINRA) at www.finra.org.

PCG Advisory, Inc., (PCG) is an affiliate of this website. PCG provides strategic advisory, investor relations and/or public relations services to emerging-growth companies.

Affiliates of Prism MarketView have a commercial and financial relationship with:

Aclarion (NASDAQ: ACON)
Actelis Networks, Inc. (NASDAQ:ASNS)
Aditxt, Inc. (NASDAQ : ADTX)
Asensus Surgical (NYSE American: ASXC)
Auddia Inc. (NASDAQ: AUUD)
Auto Parts For Less Group (OTC: FLES)
Avant Technologies (OTC:AVAI)
Bionik Laboratories (OTCPINK:BNKL)
BioStem Technologies (OTC: BSEM)
Blackboxstocks Inc. (OTC PINK:BLBX)
BranchOut Food Inc. (NASDAQ:BOF)
Cardiol Therapeutics (NASDAQ:CRDL)
Dryworld Brands (IBGR)
Empire Petroleum Corp. (OTCQB:EMPR)
Klotho Neurosciences (NASDAQ: KLTO)
LiveOne (Nasdaq:LVO)
Lexaria Bioscience Corp. (Nasdaq:LEXX)
Lipella Pharmaceuticals (Nasdaq:LIPO)
NightFood Holdings, Inc. (OTCQB: NGTF)
OncoCyte (Nasdaq:OCX)
Openlocker Holdings: (OTCQB:OLKR)
Opus Genetics (NASDAQ: IRD)
Ocuphire Pharma, Inc. (Nasdaq: OCUP)
OS Therapies (NYSE American: OSTX)
Oxford Biodynamics (AIM:OBD)
ProMIS Neurosciences (Nasdaq:PMN)
Protagenic Therapeutics (NASDAQ: PTIX)
Quoin Pharmaceuticals (Nasdaq:QNRX)
SELLAS Lifesciences (Nasdaq:SLS)
Sky Technologies: (Nasdaq:SKYX)
Soligenix, Inc. (Nasdaq:SNGX)
Soluna Holdings (Nasdaq:SLNH)
Sonotek Corporation (Nasdaq:SOTK)
SSII Innovations International (OTC: SSII)
SuperCom Ltd. (Nasdaq: SPCB)
Timber Pharmaceuticals (NYSE American:TMBR)
Verde Bio Holdings (OTC:VBHI)
Virios Therapeutics (Nasdaq:VIRI)
Vocodia Holdings (OTC:VHAI)
Zomedica Corp. (NYSE American: ZOM)

Opinions stated herein may be solely PCG or the indicated source’s, and not necessarily those of the featured Company. Officers, directors, and employees of PCG and financial analysts mentioned, and/or members of their families, may hold a position and may, from time to time, trade in these securities for their own accounts. Specific information in this regard will be furnished upon request. Trademarks are the property of their respective owners. © 2016-2021 PCG Advisory, Inc. All rights reserved.

Risk Warning:

Please be advised that stockmarket investing involves substantial risk of monetary loss. Neither Prism MarketView nor its staff recommends that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. All information contained on this website is provided as general commentary for informative and entertainment purposes, and does not constitute investment advice. Prism MarketView will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on this information, whether specifically stated in the above Terms of Service or otherwise. The value of investments and the income derived from them can go down as well as up, and you may not necessarily get back the amount you invested. Past performance of an investment is not necessarily a guide to its future performance. It may be difficult for you to sell or value certain investments or to obtain reliable information about their value or the extent of the risks to which they are exposed. Although carefully verified, data computations are not guaranteed by us or our Data Providers or affiliates and may not be complete. The value of investments may rise or fall due to the volatility of world markets, interest rates and capital values or, for investments held in overseas markets, changes in the rate of exchange in the currency in which the investments are denominated.

Further, please note that stocks about which content is published on the Site may have low market capital and/or insufficient public float. Such stocks are subject to greater risk(s) than stocks of larger companies, including greater volatility, lower liquidity and less publicly-available information. Any arrangement made between you and any third party is at your sole risk and responsibility.

Cryptocurrency Risk Warning:

Users of virtual currency may lose some or all of their investment. The value of virtual currency may change substantially in a short amount of time.
Transactions may be irreversible, even if fraudulent or accidental.
Quickly changing laws or technical problems can adversely affect the use, transfer, exchange and value of virtual currencies. There may be security risks.

No Professional Advice:

The Site does not, and is not intended to, provide investment, tax, accounting, legal or insurance advice, and is not and should not be construed as providing any of the foregoing. Neither Prism MarketView nor its staff recommends that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. All information contained on this website is provided as general commentary for informative and entertainment purposes, and does not constitute investment advice. Prism MarketView will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on this information, whether specifically stated in the above Terms of Service or otherwise.

Prism MarketView strongly recommends you conduct your own due diligence and consult a certified financial professional for personalized advice before making any investment decision. For more information on stockmarket investing, visit the securities and exchange commission (“sec”) at www.sec.gov.

Market Data:

Prism MarketView, its data providers, the financial exchanges and each of their affiliates (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Prism MarketView nor any of its information providers will be liable for any damages relating to your use of the information provided herein. Either Prism MarketView or its third party data or content providers have exclusive proprietary rights in the data and information provided. Market data limited displays are delayed at least 15 min. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. All data and information is provided as is.

Proprietary Rights:

The Site and the Content are the property of Prism MarketView or its licensors and are protected by copyright, trademarks, service marks, patents or other applicable laws. Furthermore, the collection, arrangement and assembly of the Content on the Site are the exclusive property of Prism MarketView and are likewise protected by applicable laws. Material from Prism MarketView may not be published in its entirety or redistributed without the approval of Prism MarketView.